Barry Dixon
Fitzroy, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A randomised, open-label trial of nebulised unfractionated heparin in patients mechanically ventilated for COVID-19.
Journal: Anaesthesia and intensive care
Published: March 27, 2025
Efficacy of inhaled nebulised unfractionated heparin to prevent intubation or death in hospitalised patients with COVID-19: an investigator-initiated international meta-trial of randomised clinical studies.
Journal: EClinicalMedicine
Published: February 19, 2025
Can nebulised heparin reduce acute lung injury in patients with SARS‑CoV‑2 requiring advanced respiratory support in Ireland: the CHARTER‑Ireland phase Ib/IIa, randomised, parallel-group, open-label study.
Journal: Intensive care medicine experimental
Published: December 05, 2024
The Development of Non-Invasive Optical Brain Pulse Monitoring: A Review.
Journal: Medical devices (Auckland, N.Z.)
Published: October 19, 2024
Cerebrovascular Responses in a Patient with Lundberg B Waves Following Subarachnoid Haemorrhage Assessed with a Novel Non-Invasive Brain Pulse Monitor: A Case Report.
Journal: Medical devices (Auckland, N.Z.)
Published: December 19, 2023
Right ventricular pneumatosis and extensive multi-territory air emboli in an intravenous drug user: a case report.
Journal: European heart journal. Case reports
Published: May 08, 2023
Assessment of a Non-Invasive Brain Pulse Monitor to Measure Intra-Cranial Pressure Following Acute Brain Injury.
Journal: Medical devices (Auckland, N.Z.)
Published: November 29, 2022
Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective randomised clinical studies.
Journal: British journal of clinical pharmacology
Published: May 13, 2021
Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: A multicentre case series of 98 patients.
Journal: British journal of clinical pharmacology
Published: February 08, 2021
INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies.
Journal: British journal of clinical pharmacology
Published: December 14, 2020
Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: June 21, 2020
Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence.
Journal: Critical care (London, England)
Published: June 16, 2020
Last Updated: 09/26/2026